This article originally published on The Limbic Most parents of children undergoing active cancer treatment at the RCH Children’s Cancer Centre,...
Myeloma NZ
PVd triplet therapy now on PBS for MM patients after first relapse
Pomalidomide (Pomalyst) in combination with bortezomib and dexamethasone (PVd) will be reimbursed on the PBS from 1 October for patients with...
ATAGI specifies which patients with haematological malignancy should have COVID-19 booster vax
People with blood cancers who are immunocompromised are now advised to have a third primary dose of COVID-19 vaccine with an mRNA vaccine. On 8...
‘I am screwed if it comes back’: Experts concerned by Covid’s hidden impact on blood cancer treatments
This article was originally posted on Stuff Around 21,000 Kiwis are living with blood cancer. Symptoms can be difficult to recognise, and experts...
Myeloma Research Review – Issue 39
Welcome to issue 39 of Multiple Myeloma Research Review. This issue’s selection includes research reporting that switching elderly intermediate-fit...
Newsletter: Winter 2021
Dear AllWe are now certainly in the grip of a cold winter with many parts of the country experiencing significant snow conditions. I imagine that...
CANCELLED: National Patient Seminar – 13 November 2021
CANCELLED - date to be reviewed in 2022 At this stage the Myeloma National Patient Seminar due to be held on Saturday 13th November 2021 at the...
Distress doubles for blood cancer patients during pandemic
This article was originally published on The Limbic Patients with blood cancer – including leukaemia, myeloma, and lymphoma – experience higher...
Distress doubles for blood cancer patients during pandemic
Patients with blood cancer – including leukaemia, myeloma, and lymphoma – experience higher psychological distress from risk of COVID-19 infection...
Isatuximab another string in the bow for management of RRMM
This article was originally posted on The Limbic Addition of isatuximab to carfilzomib–dexamethasone has been hailed “a new standard of care” for...
Wellington Patient Meeting 1 July
UPCOMING PATIENT MEETING You're invited to join us at our next Wellington Patient Meeting Thursday 1st July 2021, 5pm BNZ Partners Centre, Level 10,...
International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM)
Smoldering multiple myeloma (SMM) is an asymptomatic precursor state of multiple myeloma (MM). Recently, MM was redefined to include biomarkers...